85611 Prothrombin time; substitution, plasma fractions, each

Name of the Procedure:

Prothrombin Time; Substitution, Plasma Fractions, Each

Summary

Prothrombin Time (PT) is a blood test that measures how long it takes blood to clot. In the context of substitution with plasma fractions, this procedure involves replacing missing or deficient clotting factors using plasma or its components to correct abnormalities detected in the PT test.

Purpose

This procedure addresses bleeding disorders caused by deficiencies in clotting factors. The primary goal is to ensure proper blood coagulation and prevent excessive bleeding, particularly in patients with conditions like hemophilia or liver disease.

Indications

• Diagnosed bleeding disorders (e.g., hemophilia, von Willebrand disease)
• Liver dysfunction affecting clotting factors
• Monitoring anticoagulant therapy (e.g., warfarin)
• Pre-surgical evaluation for patients with suspected clotting deficiencies

Preparation

• Patients may need to fast for a few hours before the procedure.
• Blood tests to measure current clotting factor levels.
• Medication adjustments, as some drugs may affect clotting.

Procedure Description

1. A blood sample is drawn to measure the current PT.
2. If PT is prolonged, plasma fractions (plasma components containing clotting factors) are prepared.
3. The plasma fractions are administered intravenously to the patient.

4. A follow-up blood test is conducted to measure the new PT and ensure the clotting factors have corrected the deficiency.

   Tools and Equipment:

   • Blood collection supplies (needles, tubes)
   • Intravenous (IV) line and infusion equipment
   • Plasma fractions (obtained from donor plasma)

Anesthesia:

• Generally not required, though local anesthesia may be used for the blood draw or IV insertion if needed.

Duration

The entire procedure, including preparation and follow-up testing, typically takes about 1-2 hours.

Setting

Usually performed in a hospital, outpatient clinic, or specialized treatment center.

Personnel

• Hematologist or treating physician
• Nurses or phlebotomists for blood draw and IV administration

Risks and Complications

• Allergic reaction to plasma fractions
• Infection at the site of IV insertion
• Transfusion-related reactions
• In rare cases, worsening of clotting problems

Benefits

• Immediate correction of clotting deficiencies
• Reduced risk of bleeding during surgery or after injury
• Stabilization of coagulation parameters in patients with chronic conditions

Recovery

• Patients are monitored for a few hours post-procedure to ensure no adverse reactions occur.
• Follow-up blood tests may be scheduled to monitor clotting factor levels.
• Most patients can resume normal activities within a day, following specific guidelines from their healthcare provider.

Alternatives

• Recombinant clotting factors (synthetic substitutes)
• Oral or intravenous clotting factor concentrates
• Desmopressin (for mild bleeding disorders)

Pros and Cons:

• Plasma fractions are widely available but carry a small risk of transfusion reactions.
• Recombinant factors eliminate the risk of blood-borne infections but may be more expensive.
• Desmopressin is less invasive but may not be suitable for severe deficiencies.

Patient Experience

• Mild discomfort from blood draw and IV insertion.
• Possible sensation of cold or warmth during plasma infusion.
• Post-procedure fatigue or mild side effects, usually managed with rest and hydration.
• Pain management and supportive measures are provided as needed to ensure patient comfort.